Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: October 31, 2018
Reporting Period: Quarter ended September 30, 2018
Status: Emerging Growth Company (Elected not to use extended transition period for new accounting standards)
Key Financial Metrics
This Form 8-K serves as a notification of the issuance of a press release regarding the quarter ended September 30, 2018. The filing text itself does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained in the unaudited condensed consolidated financial statements and press release furnished as Exhibit 99.1, which are incorporated by reference but not reproduced in this document.
Material Changes
The filing does not explicitly detail material changes versus the prior comparable period within the text provided. It directs readers to the press release (Exhibit 99.1) for the announcement of earnings and other disclosures.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release on October 31, 2018, announcing earnings and making other disclosures.
Legal Disclaimer: Information in Item 2.02, including the incorporated press release, is furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, nor incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated October 31, 2018) for specific revenue, net income, and cash flow figures.
- Examine the unaudited condensed consolidated financial statements included in Exhibit 99.1 for detailed balance sheet and income statement data.
- Verify any forward-looking statements or guidance provided in the press release, noting the legal disclaimer regarding the "furnished" status of this information.
- Confirm the Company's status as an Emerging Growth Company and its election regarding accounting standard transition periods.